Neoplasm Metastasis
|
0.050 |
AlteredExpression
|
phenotype |
BEFREE |
Recently, researchers discovered that overexpression of FOXK2 inhibits the proliferation and metastasis of breast cancer, non-small cell lung cancer, and colorectal cancer, and is related to the clinical prognosis.
|
29520156 |
2018 |
Neoplasm Metastasis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
|
31281520 |
2019 |
Neoplasm Metastasis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
Particularly, we explore the emerging functions of FOXK2 as a regulator of a broad range of cancer features, such as cell proliferation and survival, DNA damage, metabolism, migration, invasion and metastasis.
|
30897782 |
2019 |
Neoplasm Metastasis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
We show that FOXK2 inhibits the proliferation and invasion of breast cancer cells and suppresses the growth and metastasis of breast cancer.
|
27773593 |
2016 |
Tumor Cell Invasion
|
0.040 |
AlteredExpression
|
phenotype |
BEFREE |
Here we showed that FOXK2 expression was increased and associated with tumor size, TNM stage and vascular invasion.
|
28506857 |
2017 |
Tumor Cell Invasion
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Particularly, we explore the emerging functions of FOXK2 as a regulator of a broad range of cancer features, such as cell proliferation and survival, DNA damage, metabolism, migration, invasion and metastasis.
|
30897782 |
2019 |
Tumor Cell Invasion
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
We show that FOXK2 inhibits the proliferation and invasion of breast cancer cells and suppresses the growth and metastasis of breast cancer.
|
27773593 |
2016 |
Tumor Cell Invasion
|
0.040 |
AlteredExpression
|
phenotype |
BEFREE |
Transwell and wound‑healing assays were performed to investigate the effect of FOXK2 expression on gastric cancer cell migration and invasion.
|
30221666 |
2018 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.
|
27773593 |
2016 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
FOXK2, which belongs to the fork head DNA binding protein family, has been shown to play a critical role in tumorigenesis.
|
28007600 |
2017 |
Carcinogenesis
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
The forkhead transcription factor FOXK2 plays a critical role in suppressing tumorigenesis and mediating cytotoxic drug action in breast cancer.
|
29540677 |
2018 |
Hyperactive behavior
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Conditional expression of Foxk2 in mice induced intestinal hyper-proliferation that featured enhanced DVL nuclear localization and upregulated Wnt/β-catenin signaling.
|
25805136 |
2015 |
Breast Carcinoma
|
0.140 |
AlteredExpression
|
disease |
BEFREE |
FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.
|
25740706 |
2015 |
Breast Carcinoma
|
0.140 |
GeneticVariation
|
disease |
GWASCAT |
Association analysis identifies 65 new breast cancer risk loci.
|
29059683 |
2017 |
Breast Carcinoma
|
0.140 |
AlteredExpression
|
disease |
BEFREE |
Recently, researchers discovered that overexpression of FOXK2 inhibits the proliferation and metastasis of breast cancer, non-small cell lung cancer, and colorectal cancer, and is related to the clinical prognosis.
|
29520156 |
2018 |
Breast Carcinoma
|
0.140 |
AlteredExpression
|
disease |
BEFREE |
The forkhead transcription factor FOXK2 plays a critical role in suppressing tumorigenesis and mediating cytotoxic drug action in breast cancer.
|
29540677 |
2018 |
Breast Carcinoma
|
0.140 |
AlteredExpression
|
disease |
BEFREE |
Significantly, the expression of FOXK2 is progressively lost during breast cancer progression, and low FOXK2 expression is strongly correlated with higher histologic grades, positive lymph nodes, and ERα<sup>-</sup>/PR<sup>-</sup>/HER2<sup>-</sup> status, all indicators of poor prognosis.
|
27773593 |
2016 |
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Malignant neoplasm of breast
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Recently, researchers discovered that overexpression of FOXK2 inhibits the proliferation and metastasis of breast cancer, non-small cell lung cancer, and colorectal cancer, and is related to the clinical prognosis.
|
29520156 |
2018 |
Malignant neoplasm of breast
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Significantly, the expression of FOXK2 is progressively lost during breast cancer progression, and low FOXK2 expression is strongly correlated with higher histologic grades, positive lymph nodes, and ERα<sup>-</sup>/PR<sup>-</sup>/HER2<sup>-</sup> status, all indicators of poor prognosis.
|
27773593 |
2016 |
Malignant neoplasm of breast
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
The forkhead transcription factor FOXK2 plays a critical role in suppressing tumorigenesis and mediating cytotoxic drug action in breast cancer.
|
29540677 |
2018 |
Malignant neoplasm of breast
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.
|
25740706 |
2015 |
Colorectal Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
FOXK2 overexpression promoted CRC migration, invasion and metastasis, while FOXK2 downregulation had the opposite effects.
|
31281520 |
2019 |
Colorectal Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Here, we detected FOXK2 expression and its clinical significance in colorectal cancer, which has not been fully investigated before.
|
28007600 |
2017 |
Colorectal Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Moreover, FOXK1 and FOXK2 protein levels are elevated in human colorectal cancers and correlate with DVL nuclear localization.
|
25805136 |
2015 |